Surgical Quality Improvement

Orthopaedic Surgery Outcomes

Orthopaedic Surgery ACS NSQIP Outcomes

January 1, 2020 – December 31, 2020

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall orthopaedic surgery ACS NSQIP performance benchmarked against 598 participating sites.

Orthopaedic Surgery (598 Sites)NObservedExpected
30 Day Mortality6750.44%0.38%
30 Day Morbidity6754.15%4.03%
Cardiac 6750.59%0.45%
Pneumonia6750.59%0.51%
Unplanned Intubation6750.89%0.26%
Ventilator > 48 Hours6750.59%0.10%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus6750.74%0.83%
Renal Failure6740.30%0.23%
Urinary Tract Infection (UTI)6750.44%0.65%
Surgical Site Infection (SSI)6731.63%1.78%
Sepsis6731.19%0.44%
C.diff Colitis6750.15%0.10%
Return to Operating Room (ROR)6753.11%2.40%
Readmission 6756.67%4.82%

American College of Surgeons National Surgical Quality Improvement Program, 2021.
ACS NSQIP® Semiannual Report July 8, 2021, Chicago: American College of Surgeons.

In addition to overall orthopaedic surgery ACS NSQIP® outcomes data, data specific to total knee arthroplasty (TKA) and total hip arthroplasty (THA) are provided. TKA performance is benchmarked against 481 participating sites; THA performance is benchmarked against 490 sites.